The Project Bioshield Act awaits President Bush's signature after passing the House 414-2 late Wednesday. The act, which Bush is expected to sign, sets aside $5.6 billion over 10 years for bioterror-defense initiatives and guarantees that the federal government will purchase treatments and vaccines developed against potential bioterror agents, such as anthrax, Ebola and smallpox. Drugmakers were concerned that without a guaranteed federal market they would be unable to offset product development costs. The House passed a version of the Bioshield bill last year, and the Senate passed its own version in May. The House voted to accept the Senate bill, avoiding the need for a compromise if two bills were sent to a conference committee. -- by Tony Fong
House vote brings Project Bioshield to president
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.